US Bancorp’s Arcturus Therapeutics ARCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.27K Hold
423
﹤0.01% 3696
2025
Q4
$2.59K Hold
423
﹤0.01% 3709
2025
Q3
$7.8K Sell
423
-7,364
-95% -$118K ﹤0.01% 3394
2025
Q2
$101K Buy
7,787
+4,394
+130% +$52K ﹤0.01% 2412
2025
Q1
$35.9K Buy
3,393
+2,329
+219% +$37K ﹤0.01% 2902
2024
Q4
$18.1K Sell
1,064
-23
-2% -$433 ﹤0.01% 3198
2024
Q3
$25.2K Sell
1,087
-90
-8% -$1.93K ﹤0.01% 3043
2024
Q2
$28.7K Sell
1,177
-34
-3% -$1.03K ﹤0.01% 2912
2024
Q1
$40.9K Hold
1,211
﹤0.01% 2800
2023
Q4
$38.2K Buy
1,211
+25
+2% +$594 ﹤0.01% 2794
2023
Q3
$30.3K Sell
1,186
-47
-4% -$1.45K ﹤0.01% 2680
2023
Q2
$35.4K Sell
1,233
-54
-4% -$1.47K ﹤0.01% 2691
2023
Q1
$30.8K Buy
1,287
+26
+2% +$466 ﹤0.01% 2761
2022
Q4
$21.4K Buy
1,261
+513
+69% +$8.94K ﹤0.01% 2960
2022
Q3
$11K Sell
748
-118
-14% -$1.98K ﹤0.01% 3326
2022
Q2
$14K Sell
866
-776
-47% -$15.2K ﹤0.01% 3231
2022
Q1
$44K Buy
1,642
+121
+8% +$3.09K ﹤0.01% 2688
2021
Q4
$57K Buy
1,521
+313
+26% +$12.8K ﹤0.01% 2579
2021
Q3
$58K Sell
1,208
-714
-37% -$32K ﹤0.01% 2572
2021
Q2
$65K Buy
1,922
+152
+9% +$5.14K ﹤0.01% 2529
2021
Q1
$73K Buy
1,770
+1,300
+277% +$77.5K ﹤0.01% 2420
2020
Q4
$20K Sell
470
-155
-25% -$10.5K ﹤0.01% 2904
2020
Q3
$27K Hold
625
﹤0.01% 2667
2020
Q2
$29K Hold
625
﹤0.01% 2648
2020
Q1
$8K Hold
625
﹤0.01% 3079
2019
Q4
$7K Hold
625
﹤0.01% 3182
2019
Q3
$6K Hold
625
﹤0.01% 3184
2019
Q2
$6K Hold
625
﹤0.01% 3225
2019
Q1
$4K Hold
625
﹤0.01% 3270
2018
Q4
$3K Hold
625
﹤0.01% 3301
2018
Q3
$6K Buy
+625
New +$5.2K ﹤0.01% 3256
2014
Q4
Sell
-478
Closed -$52K 3524
2014
Q3
$52K Sell
478
-30
-6% -$3.91K ﹤0.01% 2469
2014
Q2
$62K Buy
+508
New +$61.3K ﹤0.01% 2381

Other funds holding ARCT